Alberto Visintin has held various leadership roles in preclinical research and development at companies like Compass Therapeutics Inc., Genocea, Merck, Idera Pharmaceuticals, Pfizer, and Novartis Vaccines and Diagnostics. With a background in molecular biology, Alberto has led teams focused on target identification, validation, and immune therapy development in fields such as oncology, inflammation, and autoimmune diseases. Alberto's expertise in immunology and innate immunity has led to numerous publications and contributions in the field.
This person is not in the org chart